Published in BMJ on October 22, 1988
Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ (1990) 4.10
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ (2000) 3.45
Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut (1991) 1.60
An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res (2007) 1.57
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. BMJ (1995) 1.54
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int (2011) 1.43
Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut (2001) 1.29
Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut (1993) 1.24
General practitioners' use of non-steroidal anti-inflammatory drugs in Tayside and Fife regions. J R Soc Med (1992) 1.10
Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol (1991) 1.08
Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond. Br J Clin Pharmacol (2004) 1.03
Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut (1990) 0.98
Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf (2009) 0.94
Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. Postgrad Med J (1990) 0.92
Do infiltrating neutrophils contribute to the pathogenesis of indomethacin induced ulceration of the rat gastric antrum? Gut (1993) 0.92
Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID. Gut (1994) 0.91
Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. Arthritis Res (2000) 0.91
Current perspectives in NSAID-induced gastropathy. Mediators Inflamm (2013) 0.91
Newer, safer nonsteroidal anti-inflammatory drugs. Rational NSAID selection for arthritis. Can Fam Physician (1998) 0.91
Cost-effectiveness of strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease. J Gen Intern Med (2000) 0.89
Chemoprevention of colorectal cancer. Gut (1998) 0.88
Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs. Oman Med J (2011) 0.86
Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Dig Dis Sci (2001) 0.83
Non-steroidal anti-inflammatory drugs and gastrointestinal damage-problems and solutions. Postgrad Med J (2001) 0.82
Misoprostol in the prevention of gastroduodenal damage in rheumatology. Ann Rheum Dis (1992) 0.82
Psychological profiles of patients with upper gastrointestinal symptomatology induced by non-steroidal anti-inflammatory drugs. Ann Rheum Dis (1991) 0.80
Ranitidine, aspirin, food, and the stomach. BMJ (1992) 0.78
Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit. BMJ (1989) 0.78
Mast cells are critical for protection against peptic ulcers induced by the NSAID piroxicam. PLoS One (2011) 0.78
Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine. Br J Clin Pharmacol (1989) 0.77
Management of NSAID-related gastrointestinal mucosal injury. Inflammopharmacology (1999) 0.76
The role of prostaglandins in gastric mucosal protection. Trans Am Clin Climatol Assoc (1996) 0.76
Gastroprotective effect of ranitidine bismuth citrate is associated with increased mucus bismuth concentration in rats. Gut (1996) 0.76
Improving the gastrointestinal safety of NSAIDs: the development of misoprostol--from hypothesis to clinical practice. Dig Dis Sci (1998) 0.76
Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis. Ann Rheum Dis (1993) 0.76
Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans. Gut (1997) 0.76
Matching the Drug to the Patient: The rational use of antiarthritic drugs. Can Fam Physician (1991) 0.75
NSAIDs and peptic ulcers. BMJ (1990) 0.75
Impairment of salivary mucin production resulting in declined salivary viscosity during naproxen administration as a potential link to upper alimentary tract mucosal injury. Clin Transl Gastroenterol (2013) 0.75
Differential effects of misoprostol and ranitidine on the pharmacokinetics of diclofenac and gastrointestinal symptoms. Br J Clin Pharmacol (1993) 0.75
Therapy and prevention of gastric ulcer. Yale J Biol Med (1997) 0.75
The rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an H2-receptor antagonist in Nova Scotia seniors starting nonsteroidal anti-inflammatory drug therapy. Can J Gastroenterol (2010) 0.75
The influence of food, beverages and NSAIDs on gastric acid secretion and mucosal integrity. Yale J Biol Med (1997) 0.75
Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet (1986) 7.42
Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J (Clin Res Ed) (1988) 7.41
Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet (1986) 4.33
Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut (1987) 4.26
Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med (1974) 3.57
Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut (1985) 2.96
Gastroscopic evaluation of anti-inflammatory agents. Br Med J (1980) 2.51
Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med (1979) 2.22
Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol (1987) 2.05
Reappraisal of the effects of aspirin on the stomach. Lancet (1980) 1.77
Peptic ulcers induced by piroxicam. Br Med J (Clin Res Ed) (1985) 1.54
From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. Am J Med (1983) 1.50
Aspirin-induced ultrastructural changes in human gastric mucosa: correlation with potential difference. Ann Intern Med (1976) 1.49
Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. Br Med J (Clin Res Ed) (1987) 1.46
Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci (1983) 1.25
Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation. Arch Intern Med (1987) 1.25
Non-steroidal anti-inflammatory drugs and peptic ulceration. J R Coll Physicians Lond (1987) 1.23
A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol (1981) 1.20
Peptic ulcer and non-steroidal anti-inflammatory agents. Gut (1986) 1.15
Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet (1987) 1.14
Peptic ulcer and piroxicam. Br Med J (Clin Res Ed) (1985) 1.11
Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa. Gut (1982) 1.08
Pharmacology of nonsteroidal anti-inflammatory drugs. Practical review for clinicians. Am J Med (1983) 1.06
Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. Br Med J (Clin Res Ed) (1987) 0.97
NSAIDs--should every prescription carry a government health warning? Gut (1987) 0.96
Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs. Scand J Gastroenterol (1985) 0.93
The Norwegian multicenter study. Am J Med (1986) 0.92
Strategies for preventing aspirin-induced gastric bleeding. Scand J Gastroenterol Suppl (1986) 0.91
Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy. Arch Intern Med (1987) 0.88
Duodenal mucosal injury with nonsteroidal antiinflammatory drugs. J Clin Gastroenterol (1987) 0.86
Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine. J Clin Gastroenterol (1986) 0.84
Cimetidine decreases aspirin-induced gastric mucosal damage in humans. Aliment Pharmacol Ther (1987) 0.84
Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. Br Med J (Clin Res Ed) (1987) 0.82
Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine. Dig Dis Sci (1987) 0.81
Peptic ulcers induced by piroxicam. Br Med J (Clin Res Ed) (1985) 0.81
Starch Biosynthesis in Developing Wheat Grain : Evidence against the Direct Involvement of Triose Phosphates in the Metabolic Pathway. Plant Physiol (1988) 2.59
Functional homologs of the Arabidopsis RPM1 disease resistance gene in bean and pea. Plant Cell (1992) 2.15
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther (1998) 1.59
The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab (2001) 1.54
Review article: safety of bismuth in the treatment of gastrointestinal diseases. Aliment Pharmacol Ther (1996) 1.48
Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst (1995) 1.46
Pulmonary disease in patients with Marfan syndrome. Thorax (1984) 1.35
Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab (2006) 1.31
Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma. J Clin Endocrinol Metab (1981) 1.28
Complications of cryosurgery. Arch Ophthalmol (1981) 1.28
Proceedings: Inhibition by prostaglandins of fluid transport in the isolated gallbladder of the guinea-pig. Br J Pharmacol (1974) 1.19
Interaction of estrogen receptors alpha and beta with estrogen response elements. Mol Cell Endocrinol (2001) 1.09
A survey of female nursing students' knowledge, health beliefs, perceptions of risk, and risk behaviors regarding human papillomavirus and cervical cancer. J Am Acad Nurse Pract (2006) 1.08
Ranitidine and cimetidine in the healing of duodenal ulcer: meta-analysis of comparative clinical trials. Aliment Pharmacol Ther (1987) 1.05
Brainstem tumor presenting as an upper gut motility disorder. Gastroenterology (1985) 1.05
Field studies on the potential of butanone, carbon dioxide, honey extract, 1-octen-3-ol, L-lactic acid and phenols as attractants for mosquitoes. Med Vet Entomol (1990) 1.03
Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol (2000) 1.03
Equilibrium binding of estrogen receptor with DNA using fluorescence anisotropy. J Biol Chem (1997) 1.02
Stimulation of gallbladder fluid and electrolyte absorption by butyrate. J Membr Biol (1981) 1.01
Replication regions from plant-pathogenic Pseudomonas syringae plasmids are similar to ColE2-related replicons. Microbiology (1999) 0.99
Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans. Cancer Epidemiol Biomarkers Prev (1997) 0.98
Effects of bicarbonate on fluid and electrolyte transport by the guinea pig gallbladder: a bicarbonate-chloride exchange. J Membr Biol (1979) 0.97
The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol Endocrinol (1998) 0.97
Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infect Control (1986) 0.97
Chemical Warfare-A Chemical and Toxicological Review. Am J Public Health Nations Health (1944) 0.95
Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis. Aliment Pharmacol Ther (1997) 0.94
Gall-bladder water and electrolyte transport and its regulation. Gut (1983) 0.93
Ocular complications of oral contraceptives. Ophthalmic Semin (1977) 0.93
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment Pharmacol Ther (1995) 0.93
Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients. Cancer Epidemiol Biomarkers Prev (1997) 0.90
Effects of bicarbonate on fluid and electrolyte transport by guinea pig and rabbit gallbladder: stimulation of absorption. J Membr Biol (1981) 0.90
Interactive effects of 1-octen-3-ol and carbon dioxide on mosquito (Diptera: Culicidae) surveillance and control. J Med Entomol (1991) 0.89
Acute treatment of duodenal ulcer: a multicentre study to compare ranitidine 150 mg twice daily with ranitidine 300 mg once at night. Gut (1986) 0.89
Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst (1993) 0.89
Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration. Diabet Med (2010) 0.89
In vitro adherence of Lactobacillus species to vaginal epithelial cells. Am J Obstet Gynecol (1985) 0.88
A direct reading capacitance plethysmograph. Med Biol Eng (1970) 0.88
Soil carbon dioxide partial pressure and dissolved inorganic carbonate chemistry under elevated carbon dioxide and ozone. Oecologia (2004) 0.87
The safety of ranitidine in over a decade of use. Aliment Pharmacol Ther (1997) 0.87
Cimetidine in acute upper gastrointestinal bleeding. Br Med J (1979) 0.85
Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues. Rheumatol Int (1991) 0.84
GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther (1995) 0.84
Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Aliment Pharmacol Ther (1989) 0.84
Occurrence of gallstones in foetal sheep. Lab Anim (1974) 0.84
Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis. Aliment Pharmacol Ther (1998) 0.84
Effects of intra-arterial prostaglandin E2 on gallbladder fluid transport, motility, and hepatic bile in the cat. Scand J Gastroenterol (1981) 0.83
Culicoides responses to 1-octen-3-ol and carbon dioxide in salt marshes near Sea Island, Georgia, U.S.A. Med Vet Entomol (1994) 0.83
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis. Gastroenterology (1987) 0.83
Evaluation of 1-octen-3-ol as an attractant for Coquillettidia perturbans, Mansonia spp. and Culex spp. associated with phosphate mining operations. J Am Mosq Control Assoc (1990) 0.82
The timing of the evening meal affects the pattern of 24-hour intragastric acidity. Aliment Pharmacol Ther (1990) 0.82
Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime. Aliment Pharmacol Ther (1989) 0.82
Qualitative cues in the discrimination of affine-transformed minimal patterns. Perception (1996) 0.81
Contractile activity of the uterus prior to labor alters the temporal organization of spontaneous motor activity in the fetal sheep. Dev Psychobiol (1996) 0.81
Combination of ranitidine and cisapride in the treatment of reflux oesophagitis. Eur J Gastroenterol Hepatol (1995) 0.81
Genome-wide prediction of age at puberty and reproductive longevity in sows. Anim Genet (2013) 0.80
Evidence of type 2 herpes simplex infection in human coronary arteries at the time of coronary artery bypass surgery. Can J Cardiol (1995) 0.80
Can higher doses of an H2-receptor antagonist accelerate duodenal ulcer healing? Aliment Pharmacol Ther (1989) 0.80
Comparison of oestrogen-induced glycogenesis in the uterus of the rat, rabbit and sheep. Acta Endocrinol (Copenh) (1967) 0.80
Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis. Hepatology (1986) 0.79
Does co-prescription of sucralfate with ranitidine therapy enhance the healing of gastric ulcers? Am J Gastroenterol (1993) 0.79
Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole. Aliment Pharmacol Ther (1996) 0.79
Prostaglandins in chronic cholecystitis. Prostaglandins (1977) 0.79
Loxoscelism of the eyelids. Arch Ophthalmol (1980) 0.79
Neurotensin-secreting carcinoma of the bronchus. Postgrad Med J (1983) 0.79
Is bombesin a tumour marker for small-cell carcinoma? Lancet (1982) 0.78
New options in Helicobacter pylori eradication: efficacy, resistance and synergy. Scand J Gastroenterol Suppl (1998) 0.78
Oestrogen responses of rats neonatally sterilized with steroids. J Endocrinol (1969) 0.78
Potentiation of angiotensin II-induced natriuresis by indomethacin in the rat [proceedings]. Br J Pharmacol (1977) 0.78
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. Aliment Pharmacol Ther (2000) 0.78
Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs. Br J Rheumatol (1993) 0.78
Effects of a disulphonic stilbene on fluid and electrolyte transport in guinea-pig isolated gall-bladder [proceedings]. J Physiol (1978) 0.78
Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum. Gut (1984) 0.78
Calcium and colorectal epithelial cell proliferation in ulcerative colitis. Cancer Epidemiol Biomarkers Prev (1997) 0.77
Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review. Helicobacter (1997) 0.77
Influence of local estrogen administration in vaginal glycogen. Endocrinology (1968) 0.77
Does ranitidine affect blood alcohol concentrations? Pharmacotherapy (1994) 0.77
A comparison of two ranitidine intravenous infusion regimens in critically ill patients. Aliment Pharmacol Ther (1988) 0.77
The glucagon test in obstructive and hepatocellular jaundice. Postgrad Med J (1982) 0.77
Estrogenic and antiestrogenic effects of clomiphene, MER-25 and CN-55,945-27 on the rat uterus and vagina. Endocrinology (1968) 0.77
The pharmacology of histamine H2-receptor antagonists. Methods Find Exp Clin Pharmacol (1989) 0.77
Secretin and vasoactive intestinal peptide inhibit fluid absorption and induce secretion in the isolated gall-bladder of the guinea-pig [proceedings]. J Physiol (1977) 0.77
Inhibitory effect of cholera toxin on gall-bladder fluid absorption and its reversal by 2,4,6-triaminopyrimidine [proceedings]. J Physiol (1977) 0.77
A single night time dose of ranitidine in the acute treatment of gastric ulcer: a European multicentre trial. Gut (1986) 0.76
Azapropazone in the treatment of ankylosing spondylitis: a controlled clinical trial. Rheumatol Rehabil (1974) 0.76
Gallbladder secretion. Gastroenterology (1977) 0.76
Animal maturity influences prostaglandin effects on gallbladder fluid transport and smooth muscle. Eur J Pharmacol (1979) 0.76
Endocardial pacing: a percutaneous method using the subclavian vein. Br Heart J (1969) 0.75
H2 receptor antagonists: cimetidine and ranitidine. Br Med J (Clin Res Ed) (1983) 0.75
The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis. Aliment Pharmacol Ther (1992) 0.75
Gastric carcinoid associated with ranitidine and renal failure. Am J Gastroenterol (1994) 0.75
Metastatic renal carcinoma presenting with profuse haemorrhage at cardiac surgery. Postgrad Med J (1983) 0.75
Chyluria associated with bronchial carcinoma. Postgrad Med J (1981) 0.75
Proceedings: Effects of some fatty acids on gallbladder function. Br J Pharmacol (1976) 0.75
Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate. Aliment Pharmacol Ther (1991) 0.75
Fatty acids substitute for HCO3- in stimulation of gall-bladder fluid absorption [proceedings]. J Physiol (1978) 0.75
Letter: Prostaglandins and non-visualization at cholecystography. Br J Radiol (1974) 0.75
Stress-related mucosal disease. Pathophysiology, prevention, and treatment. Crit Care Clin (1995) 0.75
Quantitative requirement of the hatchling green sea turtle, Chelonia mydas, for valine, leucine, isoleucine and phenylalanine. J Nutr (1977) 0.75
Association of age with the efficacy and safety of ranitidine and cimetidine in acute duodenal ulcer disease. Age Ageing (1993) 0.75
Gallstones in foetal sheep. J Physiol (1973) 0.75